IDXX

IDEXX Laboratories

• Seeking Alpha·6d ago

  Baron Focused Growth Fund Q2 2026 Portfolio Update

• Seeking Alpha·08/31 00:10

  Tracking Terry Smith's Fundsmith 13F Portfolio - Q2 2026 Update

• Dow Jones·08/21 20:35

  Zoetis Inc. Stock Rallies 3.6%, Outperforms Peers

• Dow Jones·08/20 20:35

  Revvity Inc. Stock Advances 3.9%, Outperforms Peers

• NASDAQ·08/19 14:08

  Is IDXX Worth Buying as Growth Strength Meets a Premium Valuation?

• Seeking Alpha·08/18 09:24

  IDEXX Labs Executing, But Valuation Continues To Weigh On That Execution

• Seeking Alpha·08/18 08:38

  Zoetis: A Solid Long-Term Buy After Harsh Drawdown

• Seeking Alpha·08/16 13:05

  Notable healthcare headlines for the week: Eli Lilly, Hims & Hers Health, and Merck in focus

• NASDAQ·08/14 18:03

  IDEXX Laboratories Targets $45B Pet Diagnostics Opportunity With AI, Cancer Tests

• TipRanks·08/14 14:15

  Idexx: Neutral Stance Maintained as Long-Term Outlook Stays Opaque, Target Price Raised to $665

• TipRanks·08/14 11:40

  Analysts Are Bullish on Top Healthcare Stocks: Idexx Laboratories (IDXX), Nkarta (NKTX)

• TipRanks·08/13 18:00

  Analysts Offer Insights on Healthcare Companies: Achieve Life Sciences (ACHV) and Idexx Laboratories (IDXX)

• NASDAQ·08/11 16:28

  IDEXX (IDXX) Q2 2026 Earnings Call Transcript

• Dow Jones·08/11 14:01

  IDEXX Labs Is Maintained at Overweight by Barclays

• Dow Jones·08/11 14:01

  IDEXX Labs Price Target Cut to $710.00/Share From $800.00 by Barclays